We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+17.2%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.09B
AUM Growth
+$251M
Cap. Flow
-$136M
Cap. Flow %
-4.41%
Top 10 Hldgs %
29.06%
Holding
490
New
44
Increased
76
Reduced
237
Closed
43

Top Buys

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$58.4M
2
BIIB icon
Biogen
BIIB
+$29.7M
3
DOV icon
Dover
DOV
+$27.8M
4
EXPD icon
Expeditors International
EXPD
+$26.5M
5
DECK icon
Deckers Outdoor
DECK
+$25.6M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$37.6M
2
HD icon
Home Depot
HD
+$36.6M
3
ALSN icon
Allison Transmission
ALSN
+$34.1M
4
ADBE icon
Adobe
ADBE
+$33.6M
5
AAPL icon
Apple
AAPL
+$32.7M

Sector Composition

Rank Sector Weight
1 Technology 30.47%
2 Consumer Discretionary 14.74%
3 Industrials 14.02%
4 Healthcare 13.44%
5 Financials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZUMZ icon
276
Zumiez
ZUMZ
$330M
$75K ﹤0.01%
3,020
-180
-6% -$4.27K
IMMU
277
DELISTED
Immunomedics Inc
IMMU
$74K ﹤0.01%
3,870
-11,100
-74% -$179K
CEO
278
DELISTED
CNOOC Limited
CEO
$72K ﹤0.01%
390
+20
+5% +$3.38K
ICPT
279
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$70K ﹤0.01%
630
-2,200
-78% -$240K
EGRX
280
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$69K ﹤0.01%
1,372
-80
-6% -$3.56K
PTLA
281
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$69K ﹤0.01%
1,990
-5,600
-74% -$162K
FOLD
282
DELISTED
Amicus Therapeutics
FOLD
$67K ﹤0.01%
4,960
-16,000
-76% -$195K
INSM icon
283
Insmed
INSM
$29.4B
$67K ﹤0.01%
+2,310
New +$59.9K
SHOE
284
Shoe Station Group
SHOE
$437M
$66K ﹤0.01%
3,860
-240
-6% -$4.36K
E icon
285
ENI
E
$79.4B
$64K ﹤0.01%
1,820
+1,520
+507% +$51.6K
HALO icon
286
Halozyme
HALO
$11.6B
$64K ﹤0.01%
3,980
-12,400
-76% -$201K
PBR icon
287
Petrobras
PBR
$118B
$64K ﹤0.01%
4,017
+170
+4% +$2.7K
WFC icon
288
Wells Fargo
WFC
$265B
$60K ﹤0.01%
1,240
+40
+3% +$1.97K
C icon
289
Citigroup
C
$227B
$59K ﹤0.01%
950
-50
-5% -$3.1K
MYGN icon
290
Myriad Genetics
MYGN
$311M
$59K ﹤0.01%
1,790
-5,500
-75% -$167K
RUTH
291
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$58K ﹤0.01%
2,278
-130
-5% -$3.18K
HRTX icon
292
Heron Therapeutics
HRTX
$63.4M
$56K ﹤0.01%
2,310
-6,600
-74% -$173K
IRWD icon
293
Ironwood Pharmaceuticals
IRWD
$669M
$56K ﹤0.01%
4,979
-14,447
-74% -$161K
PTCT icon
294
PTC Therapeutics
PTCT
$6.23B
$55K ﹤0.01%
1,460
-3,900
-73% -$131K
BF
295
DELISTED
BASF AKTIENGESELLT ADS(RP1 ORD
BF
$55K ﹤0.01%
2,980
+1,340
+82% +$24.7K
ARNA
296
DELISTED
Arena Pharmaceuticals Inc
ARNA
$52K ﹤0.01%
1,170
-4,200
-78% -$193K
ENTA icon
297
Enanta Pharmaceuticals
ENTA
$402M
$50K ﹤0.01%
520
-1,300
-71% -$117K
ANAB icon
298
AnaptysBio
ANAB
$1.64B
$46K ﹤0.01%
630
-1,700
-73% -$117K
OVV icon
299
Ovintiv
OVV
$17.6B
$46K ﹤0.01%
1,264
+534
+73% +$18.3K
SSL icon
300
Sasol
SSL
$7.38B
$46K ﹤0.01%
1,490
+60
+4% +$1.82K
10 11
12
13 14

Similar funds

M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
QT
Quantbot Technologies New York $2.44B AUM 17.13% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TW
Trajan Wealth Scottsdale, Arizona $2.48B AUM 17.44% 1-Year Est. Return
KFA
Krane Funds Advisors New York $2.44B AUM 12.99% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

Smith Group Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Smith Group Asset Management held 490 positions worth $3.09B, up 8.8% from $2.83B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Smith Group Asset Management withdrew a net $136M in Q1 2019, closing 43 positions and reducing 237 holdings. Its most notable exit was Allison Transmission, an estimated $34.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Smith Group Asset Management opened a new position in Dover worth $30.2M.

  • Smith Group Asset Management's largest Q1 2019 buy was Dover: 321,614 shares worth $30.2M.
  • Smith Group Asset Management added most to Palo Alto Networks in Q1 2019, an estimated $58.4M increase.
  • Smith Group Asset Management's biggest Q1 2019 reduction was Eli Lilly, cutting an estimated $37.6M.
  • Smith Group Asset Management fully exited Allison Transmission in Q1 2019, selling an estimated $34.1M.
  • Smith Group Asset Management's ten largest holdings make up 29% of its $3.09B portfolio in Q1 2019.
  • Smith Group Asset Management opened 44 new positions and closed 43 in Q1 2019.
  • Smith Group Asset Management's portfolio value rose 8.8% quarter-over-quarter to $3.09B.

Based on Smith Group Asset Management's 13F filing for Q1 2019, filed 10 May 2019.